XtalComplete® Intelligent Crystallization Workstation

Automated crystallization processes powered by AI and robotics for accelerated drug discovery.

by XtalPi · Lab Management & ELN

Executive Summary

XtalComplete® Intelligent Crystallization Workstation is an advanced platform developed by XtalPi, a company at the forefront of AI drug discovery. This workstation leverages a powerful combination of artificial intelligence, quantum physics, and robotics to automate and optimize crystallization processes, a critical step in pharmaceutical research and development. It is designed to accelerate the identification of stable polymorphs, enhance salt screening, and facilitate structural elucidation of crystalline samples. The workstation integrates XtalPi's proprietary AI models and computational services, enabling predictive guidance for experimental conditions and polymorph stability. By automating sample handling, execution of experiments, and real-time data collection, XtalComplete aims to significantly improve throughput, reproducibility, and accuracy, often outperforming traditional human-led experimental approaches. This intelligent system provides researchers with optimized crystallization protocols and comprehensive reports, streamlining the drug discovery pipeline.

Use Cases

  • Accelerated identification of stable polymorphs for drug candidates
  • Enhanced salt screening with rational experimental design guided by AI
  • Rapid structural elucidation of crystalline samples using integrated techniques like MicroED
  • Prediction of optimal experimental conditions for crystallization processes
  • High-throughput solid-state research and development in pharmaceutical discovery

Features

Visibility

  • Real-time Experiment Monitoring: Monitor crystallization processes and data collection in real-time through an intuitive interface.
  • Result Visualization: Visualize experimental outcomes, crystal structures, and stability data for comprehensive analysis.

Intelligence

  • AI-driven Polymorph Prediction: Predict the most stable polymorphs and their crystallization conditions using advanced AI and quantum physics.
  • Automated Experimental Design: Generate optimized experimental protocols for salt screening, co-crystallization, and other crystallization challenges.
  • High-throughput Screening: Execute numerous crystallization experiments simultaneously with robotic automation for accelerated discovery.

Technical Specifications

Architecture
Quantum physics-based, AI-powered, and robotics-driven R&D platform with integration of cloud computing for accelerated polymorph prediction calculations.
Deployment
Hybrid

AI/ML Stack

  • AI models
  • Quantum Physics
  • Machine Learning

Pricing

Starting Price
Contact sales
Target Customer
Mid-Market,Enterprise

About XtalPi

XtalPi is a publicly listed biotechnology company that leverages AI, quantum physics, and robotics to accelerate drug discovery and materials research. They provide integrated solutions to streamline R&D processes, reducing time and waste in developing new therapies.

Founded: 2015 · Headquarters: Shenzhen, China · Employees: 501-1000 · Public